June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
A deep learning model to assess fundus photograph image quality and improve predictive value of deep learning models of glaucoma detection.
Author Affiliations & Notes
  • Benton Chuter
    School of Medicine, University of California San Diego, La Jolla, California, United States
  • Mark Christopher
    Hamilton Glaucoma Center, Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • Rui Fan
    Hamilton Glaucoma Center, Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
    Department of Computer Science and Engineering, University of California San Diego, La Jolla, California, United States
  • Akram Belghith
    Hamilton Glaucoma Center, Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • Christopher Bowd
    Hamilton Glaucoma Center, Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • Nicole Brye
    Hamilton Glaucoma Center, Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • James A Proudfoot
    Hamilton Glaucoma Center, Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • Jasmin Rezapour
    Hamilton Glaucoma Center, Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
    Ophthalmology, Johannes Gutenberg Universitat Mainz, Mainz, Rheinland-Pfalz, Germany
  • Massimo Antonio Fazio
    School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Michael Henry Goldbaum
    Hamilton Glaucoma Center, Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • Robert N Weinreb
    Hamilton Glaucoma Center, Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • Christopher A Girkin
    Hamilton Glaucoma Center, Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • Jeffrey M Liebmann
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • C Gustavo De Moraes
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Linda M Zangwill
    Hamilton Glaucoma Center, Shiley Eye Institute, University of California San Diego, La Jolla, California, United States
  • Footnotes
    Commercial Relationships   Benton Chuter, None; Mark Christopher, National Eye Institute (F); Rui Fan, None; Akram Belghith, None; Christopher Bowd, None; Nicole Brye, None; James Proudfoot, None; Jasmin Rezapour, German Ophthalmological Society (DOG) grant (F), Research fellowship grant of the German Research Foundation (DFG) (RE4155/1-1) (F); Massimo Fazio, EyeSight Foundation of Alabama (F), Heidelberg Engineering GmbH (F), National Eye Institute (F), Research to Prevent Blindness (F); Michael Goldbaum, None; Robert Weinreb, Aerie Pharmaceuticals (C), Allergan (C), Bausch&Lomb (C), Carl Zeiss Meditec (F), Centervue (F), Eyenovia (C), Heidelberg Engineering (F), Konan Medical (F), Meditec-Zeiss (P), Optovue (F), Toromedes (P); Christopher Girkin, EyeSight Foundation of Alabama (F), Heidelberg Engineering GmbH (F), National Eye Institute (F), Research to Prevent Blindness (F); Jeffrey Liebmann, Aerie (C), Alcon (C), Allergan (C), Bausch & Lomb (C), Bausch & Lomb (F), Carl Zeiss Meditec (C), Eyenova (C), Galimedex (C), Heidelberg Engineering (F), Heidelberg Engineering GmbH (C), National Eye Institute (F), Novartis (C), Optovue (F), Reichert (C), Reichert (F), Research to Prevent Blindness (F), Topcon (F), Valeant Pharmaceuticals (C); C Gustavo De Moraes, Belite (C), Carl Zeiss Meditec (C), Galimedix (C), Heidelberg (R), Novartis (C), Perfuse Therapeutics (C), Reichert (C), Topcon (R); Linda Zangwill, Carl Zeiss Meditec (F), Heidelberg Engineering (R), Heidelberg Engineering GmbH (F), Meditec-Zeiss (P), National Eye Institute (F), Optovue (F), Topcon Medical Systems (F)
  • Footnotes
    Support  EY11008, EY19869, EY14267, EY027510, EY026574, EY029058, P30EY022589, EY022039, EY027945, EY018926, EY028284, EY023704 (ADAGESIII), and participant retention incentive grants in the form of glaucoma medication at no cost from Novartis/Alcon Laboratories Inc, Allergan, Akorn, and Pfizer Inc. Unrestricted grant from Research to Prevent Blindness, New York, New York
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1016. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Benton Chuter, Mark Christopher, Rui Fan, Akram Belghith, Christopher Bowd, Nicole Brye, James A Proudfoot, Jasmin Rezapour, Massimo Antonio Fazio, Michael Henry Goldbaum, Robert N Weinreb, Christopher A Girkin, Jeffrey M Liebmann, C Gustavo De Moraes, Linda M Zangwill; A deep learning model to assess fundus photograph image quality and improve predictive value of deep learning models of glaucoma detection.. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1016.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To develop a deep learning model to appraise fundus photograph image quality, and to determine how the quality of photography influences the predictive value of separate glaucomatous optic neuropathy (GON) detection deep learning (DL) models.

Methods : A training dataset of 2,815 optics disc photographs acquired from healthy and GON patients as part of the Diagnostic Innovations in Glaucoma Study (DIGS) and African Descent and Glaucoma Evaluation Study (ADAGES) was used to develop a DL model to quantify the quality of photographs (0=good, 1=poor). Image quality ground truth was determined by two reviewers, with high quality images defined as sufficient to detect GON. The DL quality model was then applied to an independent test dataset of 11,350 photographs from the Ocular Hypertension Treatment Study (OHTS). A previously published DL model to detect GON in fundus photos was also applied to the OHTS data. To determine the impact of DL predicted quality on automated review of fundus photos, area under the receiver operating characteristic curve (AUC) was calculated for both good quality OHTS photographs (score 0.0-0.1) and poorer quality photographs (score > 0.1).

Results : All OHTS photographs were considered good quality by the OHTS graders. In this dataset, 68 eyes reached OHTS primary open angle glaucoma (POAG) endpoint based of the development of visual field (41 eyes) or optic disc changes (55 eyes). The diagnostic accuracy of the DL model for POAG detection performed better in good quality compared to poorer quality photographs (AUROC: (95% CI)) of 0.86 (0.79, 0.91) and 0.81 (0.73, 0.88), respectively, though the differences did not reach statistical significance. Sensitivity at 90% specificity was also higher in the good quality (0.67) compared to poorer quality (0.44) photographs. Similar trends were found when the quality score was used to evaluate the DL glaucoma detection model separately on eyes that reached a visual field endpoint or an optic disc endpoint.

Conclusions : In the OHTS data, DL models for GON detection performed better in photos with DL predicted good quality, suggesting that DL based photograph quality assessment can be used to automatically identify low quality photos for removal. Incorporating quality assessment into automated review of fundus photos may thus improve GON detection model performance

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×